📞 (586) 623-5616 ✉️ [email protected]
2026 hospice valuation multiples report with U.S. EBITDA benchmarks

Key Drivers of Hospice Valuation Multiples in 2026

A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.

Hospice valuation guide checklist showing steps to prepare financials, compliance documentation, referrals, and data room for a higher multiple.

A Hospice Owner’s Guide to Valuation Multiples: How to Avoid Exit Pitfalls

A step-by-step hospice owner’s guide to valuation multiples: how buyers think, what to prepare, how to avoid exit pitfalls, and protect your sale price.

Chart showing key drivers that impact hospice EBITDA multiples, including compliance risk, earnings quality, and referral concentration.

Hospice Multiples in the Current Market

Learn how hospice EBITDA multiples are set in today’s market—what drives the multiple, how compliance affects value, and how owners can prepare to maximize price.

Hospice valuation Q&A graphic covering EBITDA multiples, valuation methods, compliance impact, and typical valuation cost factors.

Hospice Valuation Q&A

Straight answers for hospice owners on multiples, valuation methods, compliance risk, buyer diligence, and what a professional hospice valuation typically costs.

Hospice valuation guide for owners explaining EBITDA, compliance, census mix, and strategies to maximize hospice business value

Understanding Hospice Valuation: A Guide for Owners

Hospice valuation doesn’t have to be a mystery. This guide covers the core drivers buyers measure—financials, compliance, census/service mix, reputation, and growth—plus current market dynamics and actionable ways to raise your value. When you’re ready, Vallexa Advisors can benchmark your hospice and guide a winning sale.